Update on Cardiac Tumors – review (RCD code: VI)
Journal Title: Journal of Rare Cardiovascular Diseases - Year 2014, Vol 1, Issue 8
Abstract
The prevalence of cardiac tumors is 0.021% (1 person in 5000). These data are based on a meta-analysis of pathological studies from the early decades of the twentieth century. It is likely that nowadays the incidence of cardiac tumors and primary tumors of the heart is greater. The cardiac tumors are very rare and histologically heterogeneous. These leads to, the lack of established diagnostic schemes, that would allow to distinguish cardiac tumors from metastatic tumors, intracardiac thrombus, vegetations on the valves in infective endocarditis or in the process of connective tissue diseases or thrombotic changes of the valves in the process of metastatic disease (called endocarditis marantica). Cardiac tumors may be symptomatic or found incidentally during evaluation for a seemingly unrelated problem or physical finding. In symptomatic patients, a mass can virtually always be detected by echocardiography, magnetic resonance imaging (MRI), and/or computed tomography (CT). Because symptoms may mimic other cardiac conditions, the clinical challenge is to consider the possibility of a cardiac tumor so that the appropriate diagnostic tests can be conducted. There are very few studies, assessing the results of cardiac surgery in the individual centers. There is also lack of set of standards in the chemotherapy of malignant cardiac tumors. Moreover its routine use is sometimes discussed. JRCD 2014; 1 (8): 5–10
Authors and Affiliations
Monika Komar, Giovanni La Canna, Ula Gancarczyk, Paweł Prochownik, Hanna Dziedzic‑Oleksy, Piotr Podolec
Keywords
Related Articles
- EP ID EP245410
- DOI 10.20418/jrcd.vol1no8.158
- Views 122
- Downloads 0
Left ventricular non-compaction with congenital diaphragmatic hernia causing cardiac dextroposition
A 45-year-old man with a 2-month history of breathlessness, fatigue and irregular heart rate was referred to our centre after first-ever cardiopulmonary decompensation. At presentation he was stable with heart rate of 12...
JRCD is now an open‑access journal and also accepts high‑quality papers beyond the field of rare cardiovascular diseases and disorders
n/a
JRCD is now included in the J‐Gate database, Free Medical Journals list, and JournalTOCs
We present to you the first issue of Journal of Rare Cardiovascular Diseases (JRCD) for 2018.
Prognostic value of inflammatory markers in acute coronary syndrome in a population with premature cardiovascular disease
Introduction: Inflammation plays a significant role in the development of atherosclerosis, and inflammatory markers could be used in risk assessment of patients with ischaemic heart disease. The use of such markers could...
Giant cell myocarditis: challenge of mechanical circulatory support (RCD code: III-1B.1.o)
We report the case of a young adult male who presented with acute fulminant myocarditis, deteriorated rapidly despite intra‑aortic balloon pump and inotropic support, and received a HeartMate II continuous flow left vent...